BioCentury
ARTICLE | Clinical News

Immunomedics regulatory update

May 13, 1996 7:00 AM UTC

IMMU received U.S. Patent No. 5,514,363 covering methods for labeling proteins, particularly antibody fragments, with technetium and rhenium isotopes. IMMU incorporates technetium labeling in all of i...